Zdrowie i gospodarka · 20/06/2005

FDA Releases Revised Guidance on Clozapine Tablets Bioequivalence and Dissolution Testing

The FDA has made a revised version of its 2003 guidance on in vivo bioequivalence and in vitro dissolution testing for clozapine tablets available, following a lack of comments on the previous draft published in December 2003.